Author:
Sarhan Mohammed A.,Chen Annie Y.,Michalak Tomasz I.
Publisher
Public Library of Science (PLoS)
Reference73 articles.
1. Global burden of disease (GBD) for hepatitis C. J Clin Pharmacol,2004
2. Global burden of hepatitis C: considerations for healthcare providers in the United States;M Francisco;Clin Infect Dis,2012
3. Boceprevir and telaprevir in the management of hepatitis C virus-infected patients;AA Butt;Clin Infect Dis,2012
4. VX-950, a novel hepatitis C virus (HCV) NS3–4A protease inhibitor, exhibits potent antiviral activities in HCV replicon cells;K Lin;Antimicrob Agents Chemother,2006
5. Telaprevir for previously treated chronic HCV infection;JG McHutchison;N Engl J Med,2010
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献